Canopy Set to Purchase IP from Hemp Researcher

- October 15th, 2018

Canopy Growth announced an agreement to acquire the assets of Colorado-based hemp research company ebbu.

Canopy Growth (NYSE:CGC,TSX:WEED) announced an agreement to acquire the assets of Colorado-based hemp research company ebbu.

As quoted in the press release:

Intellectual Property (“IP”) and R&D advancements achieved by ebbu’s team apply directly to Canopy Growth’s hemp and THC-rich cannabis genetic breeding program and its cannabis-infused beverage capabilities. In addition, ebbu’s IP portfolio will contribute to the clinical formulations program being executed by Canopy Health Innovations, a wholly owned subsidiary of the Company. Canopy Growth operates a rapidly emerging, field-scale hemp operation based in Saskatchewan and by applying ebbu’s IP, the Company has the potential to vastly reduce the cost of CBD production, a sought-after cannabinoid in both the wellness and medical spaces.

“Beyond the technological edge this transaction provides, we are pursuing this acquisition because Canopy shares ebbu’s core ethos of building consumer trust,” said Mark Zekulin, Co-CEO & President, Canopy Growth. “We collectively believe consumer trust is achieved by driving the scientific agenda needed to build predictable, repeatable outcomes and layering on brand power.”

Click here to read the full press release.

Source: www.newswire.ca

Get the latest Cannabis Investing stock information

Tags

Leave a Reply